ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Thematic Areas : Nanosciences and Molecular Medicine
Publisher : International Journal of Biological Macromolecules
Source : International Journal of Biological Macromolecules, Volume 110, p.133 - 139 (2018)
Keywords : amphotericin B, Macrophages, Nanoparticles, Sulfated chitosan, Targeted drug delivery
Campus : Kochi
School : Center for Nanosciences, School of Pharmacy
Center : Nanosciences
Department : Nanosciences and Molecular Medicine
Year : 2018
Abstract : The current study assesses the potential of functionalised chitosan nanoparticles (CNPs) for proficient macrophage delivery of amphotericin B (AmpB) for the management of Candida glabrata fungemia. Chitosan was functionalised by the method of sulfation by using chlorosulfonic acid and the developed compound was confirmed by FTIR, H NMR and degree of sulfation and CHNS analysis. Amphotericin B encapsulated sulfated chitosan (AmpB-SCNPs), when characterized showed a hydrodynamic diameter of 310 ± 14 nm and zeta potential of 41.5 ± 2 mV. The safety of AmpB-SCNPs was established by the alamar cytotoxicity assay in nanoparticle treated macrophages following 24 h incubation. The AmpB-SCNPs showed a significant increase in the reduction of C. glabrata in comparison with the bare AmpB and AmpB-CNPs (55.2 and 42.7 vs 11.12 cfu/ml) indicating that AmpB-SCNPs could be a promising carrier for specific delivery of AmpB to macrophages for effective treatment of Candida glabrata fungemia.
Cite this Research Publication : M. Sandhya, V., A., K., S. Maneesha, Raja, B., Dr. Jayakumar Rangasamy, and S., S., “Amphotericin B Loaded Sulfonated Chitosan Nanoparticles for Targeting Macrophages to Treat Intracellular Candida Glabrata Infections”, International Journal of Biological Macromolecules, vol. 110, pp. 133 - 139, 2018.